Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer

Abstract The copy number (CN) gain of protooncogenes is a frequent finding in gastric carcinoma (GC), but its prognostic implication remains elusive. The study aimed to characterize the clinicopathological features, including prognosis, of GCs with copy number gains in multiple protooncogenes. Three...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Meihui Li, Younghoon Kim, Tae-Shin Kim, Nam-Yun Cho, Jeong Mo Bae, Woo Ho Kim, Gyeong Hoon Kang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d0385f03259c451d86b5bed49fb52bfa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d0385f03259c451d86b5bed49fb52bfa
record_format dspace
spelling oai:doaj.org-article:d0385f03259c451d86b5bed49fb52bfa2021-12-02T17:52:12ZAssessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer10.1038/s41598-021-91652-y2045-2322https://doaj.org/article/d0385f03259c451d86b5bed49fb52bfa2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91652-yhttps://doaj.org/toc/2045-2322Abstract The copy number (CN) gain of protooncogenes is a frequent finding in gastric carcinoma (GC), but its prognostic implication remains elusive. The study aimed to characterize the clinicopathological features, including prognosis, of GCs with copy number gains in multiple protooncogenes. Three hundred thirty-three patients with advanced GC were analyzed for their gene ratios in EGFR, GATA6, IGF2, and SETDB1 using droplet dPCR (ddPCR) for an accurate assessment of CN changes in target genes. The number of GC patients with 3 or more genes with CN gain was 16 (4.8%). Compared with the GCs with 2 or less genes with CN gain, the GCs with 3 or more CN gains displayed more frequent venous invasion, a lower density of tumor-infiltrating lymphocytes, and lower methylation levels of L1 or SAT-alpha. Microsatellite instability-high tumors or Epstein–Barr virus-positive tumors were not found in the GCs with 3 or more genes with CN gain. Patients of this groups also showed the worst clinical outcomes for both overall survival and recurrence-free survival, which was persistent in the multivariate survival analyses. Our findings suggest that the ddPCR-based detection of multiple CN gain of protooncogenes might help to identify a subset of patients with poor prognosis.Meihui LiYounghoon KimTae-Shin KimNam-Yun ChoJeong Mo BaeWoo Ho KimGyeong Hoon KangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Meihui Li
Younghoon Kim
Tae-Shin Kim
Nam-Yun Cho
Jeong Mo Bae
Woo Ho Kim
Gyeong Hoon Kang
Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
description Abstract The copy number (CN) gain of protooncogenes is a frequent finding in gastric carcinoma (GC), but its prognostic implication remains elusive. The study aimed to characterize the clinicopathological features, including prognosis, of GCs with copy number gains in multiple protooncogenes. Three hundred thirty-three patients with advanced GC were analyzed for their gene ratios in EGFR, GATA6, IGF2, and SETDB1 using droplet dPCR (ddPCR) for an accurate assessment of CN changes in target genes. The number of GC patients with 3 or more genes with CN gain was 16 (4.8%). Compared with the GCs with 2 or less genes with CN gain, the GCs with 3 or more CN gains displayed more frequent venous invasion, a lower density of tumor-infiltrating lymphocytes, and lower methylation levels of L1 or SAT-alpha. Microsatellite instability-high tumors or Epstein–Barr virus-positive tumors were not found in the GCs with 3 or more genes with CN gain. Patients of this groups also showed the worst clinical outcomes for both overall survival and recurrence-free survival, which was persistent in the multivariate survival analyses. Our findings suggest that the ddPCR-based detection of multiple CN gain of protooncogenes might help to identify a subset of patients with poor prognosis.
format article
author Meihui Li
Younghoon Kim
Tae-Shin Kim
Nam-Yun Cho
Jeong Mo Bae
Woo Ho Kim
Gyeong Hoon Kang
author_facet Meihui Li
Younghoon Kim
Tae-Shin Kim
Nam-Yun Cho
Jeong Mo Bae
Woo Ho Kim
Gyeong Hoon Kang
author_sort Meihui Li
title Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
title_short Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
title_full Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
title_fullStr Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
title_full_unstemmed Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
title_sort assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d0385f03259c451d86b5bed49fb52bfa
work_keys_str_mv AT meihuili assessmentofcopynumberinprotooncogenesarepredictiveofpoorsurvivalinadvancedgastriccancer
AT younghoonkim assessmentofcopynumberinprotooncogenesarepredictiveofpoorsurvivalinadvancedgastriccancer
AT taeshinkim assessmentofcopynumberinprotooncogenesarepredictiveofpoorsurvivalinadvancedgastriccancer
AT namyuncho assessmentofcopynumberinprotooncogenesarepredictiveofpoorsurvivalinadvancedgastriccancer
AT jeongmobae assessmentofcopynumberinprotooncogenesarepredictiveofpoorsurvivalinadvancedgastriccancer
AT woohokim assessmentofcopynumberinprotooncogenesarepredictiveofpoorsurvivalinadvancedgastriccancer
AT gyeonghoonkang assessmentofcopynumberinprotooncogenesarepredictiveofpoorsurvivalinadvancedgastriccancer
_version_ 1718379254202236928